L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism

Trans Am Neurol Assoc. 1968;93:56-63.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Clinical Trials as Topic
  • Dihydroxyphenylalanine / administration & dosage
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*

Substances

  • Dihydroxyphenylalanine